medline.ch Dermatologie Psoriasis

	Investigational IL-17A antagonist in the treatment of psoriatic arthritis - a review. Expert Opin Investig Drugs Osunbor O, Nkeck JR, Adebajo AO. PMID: 42524831 [PubMed - as supplied by publisher]
	Erythrodermic psoriasis with early diagnostic uncertainty requiring multidisciplinary rheumatological management: A case report. Med Int (Lond) Danagara SR, Selvarajan T, Kannekanti L, Qamar A, Flowers A, Umer S. PMID: 42523983 [PubMed]
	Diagnostic delay in the early phase of psoriatic arthritis is independently associated with adverse pain-related cognitive responses: a multicentre cross-sectional study. Front Immunol Capparelli E, Iacovantuono M, Tasso M, Del Vescovo S, Monosi B, Conigliaro P, Faggioli P, Iannone F, Lopalco G, Chimenti MS. PMID: 42523834 [PubMed - in process]
	Investigational interleukin 17A antagonists in the treatment of psoriatic arthritis. Expert Opin Investig Drugs Osunbor O, Nkeck JR, Adebajo AO. PMID: 42522956 [PubMed - as supplied by publisher]
	Effectiveness of bimekizumab according to previous biologic exposure in patients with plaque psoriasis: a multicenter real-world study. J Dermatolog Treat Trovato E, Di Cesare A, Panduri S, Pescitelli L, Ricceri F, Lo Conte S, Brandini L, Cuccia A, Romanelli M, Rubegni P, Prignano F. PMID: 42522774 [PubMed - in process]
	Magnesium dysregulation and risk of inflammatory skin disease: A multicenter cohort study. Dermatol Online J Chalupczak N, Podolsky AS, Lipner SR. PMID: 42522535 [PubMed - indexed for MEDLINE]
	Microbiome dysbiosis in psoriatic skin among Asian populations: Insights from a systematic review and meta-analysis. Dermatol Online J Khan S, Hussain D, Ahmad H, Ahmed S. PMID: 42522515 [PubMed - in process]
	The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panel. Dermatol Online J DeBusk L, Bartley B, Armstrong AW, Bunick CG, Del Rosso J, Desai SR, Eichenfield LF, Elewski BE, Golant AK, Issa N, Stein Gold L, Swanson L, Bohman MH, Rosenberg A, Rigel D, Lebwohl M. PMID: 42522513 [PubMed - indexed for MEDLINE]
	Self-reported factors influencing adherence to oral psoriasis treatment. Dermatol Online J Shaffer BR, Lovell KK, Greenzaid JD, Zaino M, Subramanian V, Sirdeshmukh D, Wiegandt N, Richardson I, Feldman SR. PMID: 42522509 [PubMed - indexed for MEDLINE]
	Extrapolating the speed of psoriasis clearance: Head-to-head agents in clinical trials. Dermatol Online J Pfau C, Lovell KK, Ozbeki H, Feldman SR. PMID: 42522487 [PubMed - indexed for MEDLINE]
	The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains. Dermatol Online J Zakria D, Shah M, Rosenberg A, Burshtein J, DeBusk L, Altman DA, Armstrong AW, Gottlieb AB, Han G, Khattri S, Shaigany S, Weinberg JM, Lebwohl M. PMID: 42522480 [PubMed - in process]
	Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study. Front Med (Lausanne) Zhang Z, Zhang B, Wen Y, Hu Q, Jiang W, Zhuo J, Luo G, Wang Y. PMID: 42519797 [PubMed]
	Correlations between serum 25-hydroxyvitamin D levels and nailfold microvascular changes in psoriatic arthritis patients with distal interphalangeal arthritis treated with TNF inhibitors. Front Immunol Anghel D, Cobilinschi CO, Prioteas, Opri, S, Gro, Bobirc, Bojinc. PMID: 42519344 [PubMed - indexed for MEDLINE]
	Multi-omics Mendelian randomization identified adaptive immune response-related drug targets in psoriatic arthritis. Naunyn Schmiedebergs Arch Pharmacol Fan Z, Dong Q, Ding L, Zhang L, Yun X, Guo H. PMID: 42517881 [PubMed - as supplied by publisher]
	A randomized phase 2 trial of socrodeucitinib in moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol Han L, Geng S, Ding Y, Zhang S, Wang X, Hu F, Li J, Ci C, Hu Y, Chen R, Zhang J, Zhou X, Chen A, Zhang C, Lei T, Feng Y, Wang Y, Meng Z, Zhou Y, Ji M, Liu W, Wu Y, Chen Q, Wang S, Xu J. PMID: 42517728 [PubMed - as supplied by publisher]
	Image Processing for Diagnosing Psoriasis: A Machine Learning Approach to Classify Skin Lesions into Psoriasis Subtypes. Med J Islam Repub Iran Masoorian H, Gholamzadeh M, Firooz A, Safdari R. PMID: 42516629 [PubMed]
	Exploring Rare and Atypical Forms of Psoriasis: A Narrative Review. J Clin Med Bardazzi F, Benedetto G, Clarizio G, Sacchelli L, Natale A, Chessa MA, Neri I, La Placa M, Balestri R. PMID: 42513452 [PubMed]
	Treatment Switching and Drug Survival of Biologic Therapies in Psoriasis: A Real-World Italian Study Across Biologic Classes. J Clin Med Calabria S, Gisondi P, Talamonti M, Mantovani LG, Veronesi C, Degli Esposti L. PMID: 42513422 [PubMed]
	Palmoplantar pustulosis is associated with greater burden and impaired quality of life compared to psoriasis only: findings from a cross-sectional study within the Danish Skin Cohort. J Am Acad Dermatol Stave SDW, Nymand LK, Thein D, Jensen MB, Thomsen SF, Thyssen JP, Egeberg A, Alinaghi F. PMID: 42508649 [PubMed - as supplied by publisher]
	Real-World Effectiveness and Safety of Ixekizumab in Moderate-to-Severe Plaque Psoriasis in the Indian Population: A Pilot Study. Indian Dermatol Online J Singh T, Srivastava S, Venugopal R, Agarwal R, Ranjan E, Gupta P. PMID: 42507504 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 28296

Seite 1 von 1415

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung